VistaGen Therapeutics (VTGN) PT Raised to $7 at Jefferies

June 30, 2021 5:50 AM EDT
Get Alerts VTGN Hot Sheet
Price: $0.56 -3.45%

Rating Summary:
    2 Buy, 7 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Jefferies analyst Andrew Tsai raised the price target on VistaGen Therapeutics (NASDAQ: VTGN) to $7.00 (from $6.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change